Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する実験動画

多発性硬化症におけるアクソン損失

N Scolding1, R Franklin

  • 1University of Cambridge Neurology Unit, Addenbrooke's Hospital, UK.

Lancet (London, England)
|August 26, 1998
PubMed
まとめ

No abstract available in PubMed .

関連する実験動画

関連する概念動画

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Unveiling the Mysteries of Ameloblastoma: A Comprehensive Case Series on Odontogenic Lesions.

Journal of pharmacy & bioallied sciences·2025
Same author

Salivary duct carcinoma in the submandibular gland: A rare case report with differential diagnosis.

Journal of oral and maxillofacial pathology : JOMFP·2024
Same author

Anti-cancer effects of green synthesized gold nanoparticles using leaf extract of <i>Annona muricata</i>. L against squamous cell carcinoma cell line 15 through apoptotic pathway.

Dental research journal·2024
Same author

Evaluation of the cytotoxic, anti-proliferative, anti-metastatic and pro-apoptotic effect of aqueous leaf extract of <i>Annona muricata</i> on oral tongue squamous cell carcinoma cell line (SCC-15): An <i>in vitro</i> study.

Journal of oral and maxillofacial pathology : JOMFP·2023
Same author

LP2, a stable lanthipeptide derived from cAng-(1-7), exerts myeloprotective action in mice.

European journal of haematology·2023
Same author

KIF5A and the contribution of susceptibility genotypes as a predictive biomarker for multiple sclerosis.

Journal of neurology·2021
Same journal

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

Lancet (London, England)·2026
Same journal

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Lancet (London, England)·2026
Same journal

Research priorities for characterising Bundibugyo virus.

Lancet (London, England)·2026
Same journal

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Lancet (London, England)·2026
Same journal

Dual mobility total hip replacement in fractures: stability promotes patient confidence.

Lancet (London, England)·2026
Same journal

Dual mobility versus standard cups in total hip replacement for displaced femoral neck fractures (Duality): an international, multicentre, randomised, controlled, superiority trial.

Lancet (London, England)·2026
関連記事をすべて見る